| Name |
adenylate cyclase 5 |
adenylate cyclase 2 |
| Structure |
|
No pdb structure
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| GWAS |
|
- Anxiety and stress-related disorders ( 31116379
)
- Atorvastatin-induced myopathy ( 31220337
)
- Bipolar disorder ( 31043756
34002096
24618891
)
- Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder ( 27890468
)
- Bipolar disorder or attention deficit hyperactivity disorder ( 27890468
)
- Bipolar I disorder ( 31043756
)
- Caffeine consumption from coffee ( 33287642
)
- Caffeine consumption from coffee or tea ( 33287642
)
- Capecitabine sensitivity ( 22864933
)
- Coffee consumption ( 31046077
)
- Cognitive decline rate in late mild cognitive impairment ( 26252872
)
- Food addiction ( 27106561
)
- LDL cholesterol levels in HIV infection ( 33109212
)
- Mean arterial pressure (alcohol consumption interaction) ( 24376456
)
- Oropharynx cancer ( 27749845
)
- Pars opercularis volume ( 31530798
)
- Plasma factor VII activating protease levels ( 30070759
)
- Posterior-cingulate cortex volume ( 31530798
)
- Smoking status (heavy vs never) ( 26423011
)
- Visceral fat ( 22589738
)
|
| Novel Interactors |
None recorded
|
8 novel interactors:
AHRR
CDH18
GCDH
ISL1
NUF2
OBP2A
RDH12
SLC9A3
|
| Interacting Genes |
7 interacting genes:
ADCY2
GNAI1
GNAS
PRKACA
PRKCA
PRKCZ
RGS2
|
6 interacting genes:
ADCY1
ADCY5
DRD4
F2RL1
GNAS
GNG2
|
| Entrez ID |
111 |
108 |
| HPRD ID |
08973
|
00052
|
| Ensembl ID |
ENSG00000173175
|
ENSG00000078295
|
| Uniprot IDs |
A0A384P5Q5
A0A8V8TP58
B3KWA8
B7Z2C7
O95622
|
Q08462
Q71UM8
|
| PDB IDs |
8SL3
8SL4
|
Not available
|
| GO Terms Enriched among Interactors |
|
|